EGF Theramed Valuation
| EVAHF Stock | USD 0.21 0.02 10.53% |
EGF Theramed seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of EGF Theramed Health from analyzing the firm fundamentals such as shares owned by insiders of 0.09 %, and Current Valuation of 4.72 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that EGF Theramed's price fluctuation is out of control at this time. Calculation of the real value of EGF Theramed Health is based on 3 months time horizon. Increasing EGF Theramed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the EGF pink sheet is determined by what a typical buyer is willing to pay for full or partial control of EGF Theramed Health. Since EGF Theramed is currently traded on the exchange, buyers and sellers on that exchange determine the market value of EGF Pink Sheet. However, EGF Theramed's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.21 | Real 0.16 | Hype 0.21 | Naive 0.29 |
The real value of EGF Pink Sheet, also known as its intrinsic value, is the underlying worth of EGF Theramed Health Company, which is reflected in its stock price. It is based on EGF Theramed's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of EGF Theramed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of EGF Theramed Health helps investors to forecast how EGF pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of EGF Theramed more accurately as focusing exclusively on EGF Theramed's fundamentals will not take into account other important factors: EGF Theramed Total Value Analysis
EGF Theramed Health is currently forecasted to have takeover price of 4.72 M with market capitalization of 12.41 M, debt of 1.23 M, and cash on hands of 51.98 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the EGF Theramed fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4.72 M | 12.41 M | 1.23 M | 51.98 K |
EGF Theramed Asset Utilization
One of the ways to look at asset utilization of EGF is to check how much profit was generated for every dollar of assets it reports. EGF Theramed Health shows a negative utilization of assets of -0.72 percent, losing $0.007188 for each dollar of assets held by the firm. Inefficient asset utilization denotes the company is being less productive with each dollar of assets it shows. Put another way, asset utilization of EGF Theramed Health shows how inadequate it operates for each dollar spent on its assets.EGF Theramed Ownership Allocation
The market capitalization of EGF Theramed Health is $12.41 Million. Roughly 99.91 percent of EGF Theramed outstanding shares are held by general public with 0.088 (percent) owned by insiders and only 0.0 % by other corporate entities. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.EGF Theramed Profitability Analysis
Net Loss for the year was (1.35 M) with loss before overhead, payroll, taxes, and interest of (105.22 K).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates EGF Theramed's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in EGF Theramed and how it compares across the competition.
About EGF Theramed Valuation
The pink sheet valuation mechanism determines EGF Theramed's current worth on a weekly basis. Our valuation model uses a comparative analysis of EGF Theramed. We calculate exposure to EGF Theramed's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of EGF Theramed's related companies.EGF Theramed Health Corp. provides psychedelic drugs for the treatment of mental health. It offers psychedelics for the treatment of conditions, such as treatment-resistant depression, anxiety, PTSD, and depression. Egf Theramed operates under Health Information Services classification in the United States and is traded on OTC Exchange.
8 Steps to conduct EGF Theramed's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates EGF Theramed's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct EGF Theramed's valuation analysis, follow these 8 steps:- Gather financial information: Obtain EGF Theramed's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine EGF Theramed's revenue streams: Identify EGF Theramed's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research EGF Theramed's industry and market trends, including the size of the market, growth rate, and competition.
- Establish EGF Theramed's growth potential: Evaluate EGF Theramed's management, business model, and growth potential.
- Determine EGF Theramed's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate EGF Theramed's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
EGF Theramed Growth Indicators
Investing in growth stocks can be very risky. If the company such as EGF Theramed does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 2.2 M | |
| Retained Earnings | -55.2 M |
Complementary Tools for EGF Pink Sheet analysis
When running EGF Theramed's price analysis, check to measure EGF Theramed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EGF Theramed is operating at the current time. Most of EGF Theramed's value examination focuses on studying past and present price action to predict the probability of EGF Theramed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EGF Theramed's price. Additionally, you may evaluate how the addition of EGF Theramed to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |